Kumud Kalia - Mar 1, 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Information Officer
Signature
/s/ John Saia, as attorney-in-fact for Kalia Kumud
Stock symbol
GH
Transactions as of
Mar 1, 2023
Transactions value $
-$214,689
Form type
4
Date filed
3/3/2023, 03:59 PM
Previous filing
Jan 9, 2023
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +711 +9.75% $0.00 8.01K Mar 1, 2023 Direct
transaction GH COMMON STOCK Tax liability -$7.22K -246 -3.07% $29.36 7.76K Mar 1, 2023 Direct F1
transaction GH COMMON STOCK Sale -$207K -6.5K -83.75% $31.92 1.26K Mar 3, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -711 -9.1% $0.00 7.1K Mar 1, 2023 COMMON STOCK 711 $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 Represents the weighted average price of shares sold at prices that ranged from $31.87 to $31.99.
F3 The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
F4 Not applicable for Restricted Stock Units.

Remarks:

Table I, includes 242 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2022.